HELLO: An Evaluation of Health Outcomes for Mako Hip Replacement
Study Details
Study Description
Brief Summary
To assess clinical outcomes and surgery related resource use in the year post surgery for patients undergoing hip replacement using the Mako Robo
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
This is an observational cohort study. It evaluates the recovery of 200 patients who are having routine robotic hip replacement surgery at a Nuffield Hospital in Bournemouth. Any complications from the surgery, or readmissions to hospital, will be reported. Investigators will measure how accurately the surgeon, assisted by the robotic-arm, positions the hip implant during the surgery using x-rays taken as part of routine care. The study also monitors the progress of rehabilitation by assessing pain and functional ability in the year following surgery, and will investigate whether there is an association between this recovery and a measurement of an area of muscle in the pelvic region, taken from a routine CT scan.
Patients will be asked to come to the Orthopaedic Research Institute at Bournemouth University to be assessed before they have surgery, and again at 3 weeks, 6-8 weeks, 3 months, 6 months and 12 months following surgery. At these visits they will be asked about their pain, how well they can do daily activities, and their quality of life. They will be assessed on their ability to sit-to-stand five times, walk for 40m, and climb some stairs. At each visit, except the three weeks visit, they will also have their gait tested on a specialised clinical treadmill, and the muscle strength in their legs measured. They will also be measured for oedema at baseline, 3 weeks and 6-8 weeks using a Fit3D ProScanner. These visits are in addition to the routine clinical follow-up visits at Nuffield Hospital. Participants will also be invited to wear a wrist activity monitor for at least three consecutive days prior to surgery and for the 6 weeks following discharge so that their activity can be recorded.
Surgery-related resource use of the procedure will also be reported, such as length of hospital stay, time in theatre, unplanned hospital visits, non-routine medication, outpatient appointments and physiotherapy appointments.
Study Design
Outcome Measures
Primary Outcome Measures
- The measurement of surgical complications post surgery [1 Year post surgery]
This study's primary outcome is to report on surgical complications. Events will be sub-classified as device (prosthesis or robot) or surgeon related.
- The measurement of readmission post surgery [1 Year post surgery]
This study's primary outcome is to report on surgical complications. Events will be sub-classified as device (prosthesis or robot) or surgeon related.
Secondary Outcome Measures
- Accuracy of component positioning [1 Year post surgery]
Placement of prosthetic components will be evaluated by assessing radiographs
- Functional Assessments - Chair stand [1 Year post surgery]
30 s Chair Stand test as recommended by the Osteoarthritis Research Society International (OARSI). Assessment will be done prior to surgery, and again at 3 weeks, 6-8 weeks, 3 months, 6 months and 1 year following surgery
- Functional Assessments - Fast paced Walk [1 Year post surgery]
40m fast-paced walk test as recommended by the Osteoarthritis Research Society International (OARSI). Assessment will be done prior to surgery, and again at 3 weeks, 6-8 weeks, 3 months, 6 months and 1 year following surgery
- Functional Assessments - Stair Climb [1 Year post surgery]
Stair climb test as recommended by the Osteoarthritis Research Society International (OARSI). Assessment will be done prior to surgery, and again at 3 weeks, 6-8 weeks, 3 months, 6 months and 1 year following surgery
- Gait analysis [1 Year post surgery]
Participants' gait will be analysed using the GRAIL MotekForce at baseline, 6-8 weeks, 3 months, 6 months and 1 year following surgery.
- Muscle Testing [1 Year post surgery]
Participants' muscle strength will be analysed using the Primus BTE at baseline, 6-8 weeks, 3 months, 6 months and 1 year following surgery.
- Measurement of pre-operative psoas muscle mass [Pre-Operative]
This measurement will be taken from the pre-surgery CT scan
- Patient Reported Outcome Measures - EQ-5D Quality of Life Score [6 Months post surgery]
EQ-5D Quality of Life Score will be assessed at pre-surgery and at 6 months.
- Patient Reported Outcome Measures - The Pain Catastrophizing Score (PCS) [Pre-Operative]
The Pain Catastrophizing Score (PCS) will be assessed prior to surgery.
- Patient Reported Outcome Measures - The Hip Disability and Osteoarthritis Outcome Score (HOOS) [1 Year post surgery]
The Hip Disability and Osteoarthritis Outcome Score (HOOS) will be assessed at pre-surgery, 3 weeks, 6-8 weeks, 3 month, 6 months and 1 year following surgery
- Surgery related resource use - length of stay in hospital [1 Year post surgery]
Data will be reported on surgery-related use of resources for length of stay in hospital
- Surgery related resource use - time in theatre [1 Year post surgery]
Data will be reported on surgery-related use of resources for time in theatre
- Surgery related resource use - unplanned hospital visits [1 Year post surgery]
Data will be reported on surgery-related use of resources for unplanned hospital visits
- Surgery related resource use - non-routine medication [1 Year post surgery]
Data will be reported on surgery-related use of resources for non-routine medication
- Surgery related resource use - number of outpatient appointments [1 Year post surgery]
Data will be reported on surgery-related use of resources for number of outpatient appointments
- Surgery related resource use - number of physiotherapy appointments [1 Year post surgery]
Data will be reported on surgery-related use of resources for number of physiotherapy appointments.
- Monitoring of physical activity [6-8 weeks following surgery]
Participants will be invited to wear an activity monitor on their wrist for at least three consecutive days prior to surgery, and for the 6-8 weeks following discharge
- Measurement of oedema [6-8 weeks following surgery]
Participants will be assessed for oedema using a Fit3D ProScanner at baseline, 3 weeks and 6-8 weeks following surgery.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis, suitable for unilateral primary hip replacement;
-
Rheumatoid arthritis;
-
Correction of functional deformity;
-
Voluntary written Informed Consent obtained.
-
Participant able to complete study follow-up.
Exclusion Criteria:
-
Prospect for recovery to independent mobility compromised by known coexistent medical problems;
-
Requiring revision hip replacement;
-
Previous hip replacement (resurfacing or THR) on the contralateral side, with outcome achieving an Oxford Hip score <18 points;
-
Likely post-operative leg length inequality >5cm;
-
Neuromuscular disease affecting hip (Parkinson's, cerebral palsy, other spasticity);
-
Primary or metastatic tumor involving this hip;
-
Loss of abductor musculature, poor bone stock, or poor skin coverage around the hip joint;
-
Previous arthrodesis or excision arthroplasty
-
Acetabular deficiency - >2cm superior loss acetabular dome or >1.5cm protrusion acetabulae or wall deficiency> half a wall;
-
Dysplasia (DDH) with >2.5cm subluxation or complete dislocation;
-
Body mass index > 40kg/m2;
-
Active or previous or suspected infection in this hip;
-
Sepsis or osteomyelitis;
-
Known sensitivity to device materials;
-
Not physically able to use Grail gait lab and Primus muscle testing equipment;
-
Women judged by the Investigator to be of childbearing potential who are pregnant, nursing, or planning to become pregnant, and those who do not agree to remain on an acceptable method of birth control throughout the entire study period;
-
Unable to provide informed consent (insufficient English, cognitive disorder such as dementia, psychiatric illness);
-
Unable to complete follow-ups (life expectancy <5 years, insufficient English, lives overseas, unable to return easily).
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Nuffield Health Bournemouth | Bournemouth | United Kingdom | BH1 1RW | |
| 2 | Orthopaedic Research Institute Bournemouth University | Bournemouth | United Kingdom | BH8 8FT |
Sponsors and Collaborators
- Bournemouth University
- Nuffield Health Bournemouth
- Orthopaedic Research Institute
- Stryker Orthopaedics
Investigators
- Study Director: Tom Wainwright, Professor
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ORI/Mako/18